Q1FY26 Revenue at ₹496 Cr; EBITDA at ₹125 Cr; Net Profit at ₹60 CrHYDERABAD, India, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused, ...

Furthermore, the content of this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, Thursday, August 7, 2025. Lisata Therapeutics ...

Discover Avadel Pharmaceuticals' Q2 2025 milestones: record-high LUMRYZ sales, raised revenue guidance, and first net income since launch.

FDA accepts a new formulation of piflufolastat F 18, enhancing prostate cancer imaging access and efficiency, with a target ...

In the third part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, ...

Lash serums promise longer lashes – but some contain glaucoma drugs that can cause darkened skin, sunken eyes and even ...

Merck has announced the acquisition of SpringWorks, which is expected to close this year, for an enterprise value of EUR 3 billion. While the deal appears expensive at an 18 times price/sales multiple ...

Millions of people are alive today because of leukemia therapies that arose from UC research, including retired Army Major ...

WEHI researchers have visualized a key protein complex in malaria parasites for the first time, uncovering a new target for ...

In the second part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, ...

The Green Chemistry Research Project at Hiram College explores innovative solutions to some of today’s most pressing ...

Medical probe steriliser Nanosonics has hit the US double jackpot, with the FDA approving iterations of its original Trophon device.